Assessment of Risk Factors for Atrial Fibrillation With a Particular Focus on Echocardiographic Parameters, in Patients With Acute Myocardial Infarction

急性心肌梗死患者房颤风险因素评估,尤其关注超声心动图参数

阅读:1

Abstract

BACKGROUND: Atrial fibrillation is the most common arrhythmia worldwide, affecting between 2% and 4% of population. The projected further progression is a reason to consider AF as a global epidemic problem. The efficiency in diagnosing new cases is still unsatisfactory. METHODS: The prospective study included 74 patients hospitalized for acute myocardial infarction. Echocardiography with advanced assessment of the left atrium was performed on all patients. R Statistical Software was used for statistical and graphical processing. RESULTS: Atrial fibrillation was first diagnosed in 13.5% of patients with acute myocardial infarction, and in 5.4% of the patients the diagnosis was made during the long-term follow-up period. Analysis of the data collected showed that patients with arrythmia were older (71.79 vs 63.5 years; p = 0.047), had a higher BMI (30.15 vs 26.76 kg/m(2); p = 0.039) and had a higher CHA(2)DS(2) VASc score (4.14 vs 3.02 points). Among the echocardiographic parameters, those that significantly differentiated patients with arrythmia included larger LA area (21.62 vs 18.84 cm(2); p = 0.027), lower LAEF 4CH (43.46 vs 55.93%; p = 0.029), lower LAEF mean (44.08 vs 55.63%; p = 0.014), lower EI (1.03 vs 1.49; p = 0.032), lower LASr 4CH (19.08 vs 26.72%; p = 0.020), lower LASr mean (18.62 vs 26.73%; p = 0.009), higher E/e' (12.62 vs 9.58; p = 0.01), higher LASI (0.95 vs 0.45; p = 0.016). CONCLUSIONS: Among the echocardiographic parameters, those that may indicate an increased risk of atrial fibrillation and could be implemented in clinical practice are LASr and LASI. Determining them in risk profiling and the implementation of individualized arrhythmia detection methods could increase diagnostic efficiency.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。